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Summary 
Recently, a severe combined immunodeficiency syndrome with a deficiency of CD8 + periph- 
eral T  cells and a TCR  signal transduction  defect in peripheral CD4 + T  cells  was associated 
with mutations in ZAP-70. Since TCR signaling is required in developmental decisions result- 
ing in mature CD4  (and CD8)  T  cells,  the presence of peripheral  CD4 +  T  cells  expressing 
TCRs incapable of signaling in these patients is paradoxical. Here, we show that the TCRs on 
thymocytes, but not peripheral T  cells,  from a ZAP-70-deficient patient are capable of signal- 
ing. Moreover, the TCR on a thymocyte line derived from this patient can signal, and the ho- 
mologous kinase Syk is present at high levels and is tyrosine phosphorylated after TCR stimu- 
lation. Thus, Syk may compensate for the loss of ZAP-70 and account for the thymic selection 
of at least a subset ofT cells (CD4 +) in ZAP-70-deficient patients. 
T 
he  severe  combined  immunodeficiency  syndrome 
(SCID) 1 comprises a group of heterogeneous disorders 
affecting the functional activity of both T  and B  lympho- 
cytes  (1).  Phenotypically, infants with SCID can have ei- 
ther  a  marked  deficiency  in  circulating  lymphocytes  or 
normal numbers of T  and B ceils whose function is abnor- 
mal. T  ceil immunity abnormalities in SCID have been as- 
sociated with an absence ofT cell differentiation (2), failure 
to produce IL-2 (3),  and mutations in the genes encoding 
the ~/chain of the IL-2 receptor (4,  5) or the CD3 ~/sub- 
unit  of the  TCR  (6).  Recent  studies  have also  described 
defects  in  the  ZAP-70  protein  tyrosine  kinase  (PTK), 
which is involved in signal transduction through the TCR 
(7-9). 
Stimulation of TCRs on T  lymphocytes leads to the ty- 
rosine  phosphorylation  of specific  intracellular  substrates 
and the subsequent rapid increase in cytoplasmic free Ca  z+ 
levels ([Ca2+]i)  (10-14).  Since the component chains of the 
TCR  do  not  contain  an  intrinsic  kinase  domain,  signal 
transduction  must occur via association of these  receptors 
with intracellular protein kinases (PTKs). Two PTK fami- 
1Abbreviations used in  this paper: [Ca2+]i, cytoplasmic free Ca  2+  levels; 
HTLV, human T tymphotropic  virus; PLC, phospholipase  C; PTK, pro- 
tein tryosine kinase; SCID, severe combined immunodeficiency syn- 
drome. 
lies have been shown to interact with the TCR. Members 
of the Src family of PTKs, Fyn and Lck, have been impli- 
cated in T lymphocyte signal transduction and in T  cell dif- 
ferentiation  (13,  14).  Fyn has been coimmunoprecipitated 
with the TCR (15) and inactivation ofthefyn  gene impairs 
signal transduction in mature thymocytes (16,  17).  In a T 
cell line (18)  and cytolytic T  cell clone (19),  Lck has been 
shown  to be required  for the induction  of tyrosine phos- 
phoproteins, including the TCR CD3 and ~ chains. More- 
over, Lck-deficient mice exhibit a profound failure of early 
T  cell development with few thymocytes and circulating T 
cells that exhibit an impaired response to TCR stimuli (20). 
A second family of PTKs, consisting of ZAP-70 and Syk, 
have also been implicated in TCR-mediated signaling.  In 
T  cell lines, ZAP-70 and Syk are recruited to the phosphor- 
ylated CD3 and ~ subunits, where they are in turn tyrosine 
phosphorylated after TCR stimulation (21,  22). The failure 
of the recruitment of ZAP-70 to the TCR in an Lck-defi- 
cient T  cell line suggests that it plays a role downstream of 
Lck  (23).  It was  hypothesized,  therefore,  that  the  TCR 
may interact with members of these two families of PTKs 
sequentially  (24).  In  this  model,  an  Src  family  member 
would first phosphorylate tyrosine residues contained in the 
and CD3 chains.  Only then would ZAP-70 and/or Syk 
be recruited to the receptor complex via an interaction in- 
volving both of their  SH2  domains  with  the phosphory- 
lated  receptor  chains.  Once  recruited  to  the  receptor, 
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suiting in a synergistic increase in PTK activity. 
ZAP-70  and  Syk  are  structurally  homologous,  having 
two tandemly arranged SH2 domains and a COOH-termi- 
hal kinase domain (25, 26). ZAP-70 protein is expressed in 
T  ceils and NK cells  (26). It is also expressed in thymocytes 
at  levels  comparable  to  those  found  in  peripheral  CD4 + 
and CD8 + T  cells (22). A  role for ZAP-70 has been estab- 
lished in T  cells (see below). Syk has been most clearly im- 
plicated in B  cell mlg,  as well as in mast cell Fc~RI signal 
transduction  (27-30).  After mlg or Fc~RI stimulation,  Syk 
associates  with  the  tyrosine-phosphorylated,  non-ligand- 
binding chains of both of these receptors. Genetic evidence 
for the requisite  function of Syk in mlg signal transduction 
function has been  obtained  in  a  chicken B  cell  line  (30). 
The function of Syk in T  cells is not as clear, however. Syk 
protein  is present  at  higher levels in thymocytes than  pe- 
ripheral T  cells,  but the level of Syk in peripheral  T  cells is 
only ~1/12-1/15  of the  level in B  cells  (22).  In a  T  cell 
line  expressing relatively high levels of Syk, its association 
with the TCR  and its tyrosine phosphorylation after recep- 
tor stimulation has been observed (31). Although some data 
suggest that Syk can interact with the TCR  independently 
of Lck involvement and TCR  engagement (31), this is not 
consistent with our published and more recent observations 
(22)  (Chu,  D.,  N.  van  Oers,  and  A.  Weiss,  unpublished 
data). 
Three recent studies have provided evidence that the ab- 
sence of ZAP-70 protein, which results from inherited mu- 
tations,  leads  to  a  form of SCID  (7-9).  This  syndrome is 
characterized  by the  absence  of peripheral  CD8 +  T  cells 
and a failure of peripheral CD4 + T  cells to signal normally 
through the TCR.  Since T  cell differentiation  and thymic 
selection  appear  to  require  TCR-mediated  signaling,  the 
emergence of CD4 + T  cells with TCRs that cannot signal 
requires explanation.  Here, we show that thymocytes from 
a ZAP-70-deficient patient  can indeed signal through the 
TCR. This is in marked contrast to the patient's peripheral 
T  cells,  which fail to respond to TCR  stimuli.  Using a hu- 
man  T  lymphotropic  virus  (HTLV-1)-transformed  thy- 
mocyte line  from this  patient,  we  provide  evidence  that 
Syk may compensate for the loss of ZAP-70 in the thymus. 
These results  emphasize the  critical but perhaps redundant 
role for this family of PTKs in T  cell differentiation and se- 
lection. 
Materials  and Methods 
Cells and Antibodies.  PBMCs were isolated  by density  gradi- 
ent centrifugation from the patient and normal volunteers.  A thy- 
mic biopsy was obtained from the patient after informed consent 
from a parent.  A portion of normal thymus was obtained from a 
patient undergoing cardiac  surgery.  Single  cell suspensions  from 
the  thymus  were  obtained  by  density  gradient  centrifugation. 
HTLV-1 transformation ofthymocytes from the patient and from 
an  immunologically normal  individual  undergoing cardiac  sur- 
gery was performed as described  (32). The HTLV-1 lines were 
maintained in RPMI 1649 medium supplemented with antibiot- 
ics, glutamine, FBS (10%), and IL-2 (20 U/ml). The phenotype 
of the lines was similar; they each expressed  the TCR-c~/[3 (no 
TCR-8 was detected),  CD4, and CD25, but they were CD8 de- 
ficient. 
The  following mAbs were  used  in  these  studies:  anti-Leu4 
(anti-CD3),  antMx/[3  (WT31),  and  biotin  derivatives  (Becton 
Dickinson & Co., Mountain View, CA); anti-Leu3-biotin (anti- 
CD4; Becton Dickinson); 4G10 (antiphosphotyrosine)  and anti- 
phospholipase-~/1  (anti-PLC-',/l) (Upstate Biologicals,  Inc., Lake 
Placid,  NY);  and  anti-TCR-B  (T-Cell  Diagnostics,  Wobum, 
MA);  anti-Lck  (a  kind  gift  from  Dr.  J.  Bolen);  anti-CD3 
(DAKO, Santa Barbara, CA); a mix ofmAbs G3/B2, anti-TCR-~ 
(33); and  2F3,  anti-ZAP-70  (23).  Rabbit  heterosera  used  in- 
cluded:  anti-ZAP-70  (26); anti-Fyn  (a  kind  gift  from  Dr.  J. 
Bolen, Bristol-Myers Squibb Pharmaceutical Research Institute, 
Princeton, NJ); anti-Syk (a kind gift from Dr. A. DeFranco, Uni- 
versity  of California,  San  Francisco,  CA);  anti-TCR-~  (a  kind 
gift  from Dr.  A.  Weissman,  National  Institutes  of Health,  Be- 
thesda,  MD);  and anti-FcR',/ (a kind gift from Dr. J.  P.  Kinet, 
National Institutes of Health, Bethesda,  MD). 
Flow Cytometric Analysis of Immunofluorescent Staining of PBMC 
and Thymocytes.  Standard  direct  immunofluorescent  methods 
were  used  to  double  stain  for  CD4  and  CD8  expression  on 
PBMC  and  thymocytes  using  antibodies  from  Coulter  Corp. 
(Hialeah,  FL). The cells were analyzed on an Epics Profile  I flow 
cytometer (Coulter). 
Changes in [Ca2+]i.  After  the  loading  of PBMCs  or  thy- 
mocytes with  indo-1  (Molecular  Probes,  Eugene,  OR)  (1  p,g/ 
ml),  changes  in  [Ca2+]i in  response  to  Leu 4  mAb  (anti-Cl)3) 
were monitored in a spectrofluorimeter (F4010; Hitachi, Tokyo, 
Japan)  and  calculated  as  previously described  (34). Changes  m 
[Ca2+]i in indo-l-loaded, HTLV-l-transformed thymocyte lines 
were monitored in a SPEX spectrofluorimeter at 37~  according 
to previously published  methods (9). Cells were stimulated  with 
biotinylated anti-Leu4 mAb (2 ~zg/ml) followed by the addition 
ofstreptavidin (10 p,g/ml; Calbiochem, LaJolla, CA). 
lmmunoprecipitation and Western Blot Analyses.  Methods  are iden- 
tical with those previously described  in detail  (18, 22,  23),  with 
the exception that in some experiments enzyme-linked chemolu- 
minescence (ECL) was used to detect proteins  by Western blot- 
ting.  Cells were stimulated  in PBS at 37~  at a concentration of 
108 cells per ml with biotinylated anti-Leu4 mAb and streptavi- 
din.  In some experiments,  biotinylated anti-Leu3 mAb was also 
included.  Cells  were  lysed  in  a  buffer  containing  1%  NP-4{}. 
Whole  cell  lysates from  1-2  X  106  unstimulated  or stintulated 
cells were diluted in SDS before analysis by Western blotting. For 
immunoprecipitations, lysates derived from 1-5 X  10  v cells were 
used. 
Northern Blot Analysis.  Whole cell RNA was obtained using 
RNAsol (Teltest,  Inc., Friendswood, TX).  30 b~g of RNA was 
electrophoresed  in  a  I%  agarose  gel  and  transferred  to  nylon 
membranes.  Duplicate filters were hybridized with either a full- 
length ZAP-70 cDNA probe or a ~-actin probe that had been ra- 
diolabeled  with  32p  (26). Washed blots  were  assessed by auto- 
radiography. 
Results 
Phenotype  of  Peripheral  Blood  T  Lymphocytes  and  Thy- 
mocytes.  The patient was a 4 1/2-too-old white male with 
a 2-mo history of multiple infections and chronic diarrhea. 
A  first child, he was the product of a consanguineous rela- 
tionship.  Initial  evaluation  revealed panhypogammaglobu- 
linemia  and  normal  numbers  of circulating  lymphocytes. 
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Figure 1.  Deficiency ofCD8  + T cells in the peripheral blood and thy- 
mus of a patient with SCID. PBMC (A) and thymocytes (B) were ob- 
tained and stained with anti-CD4 (phycoerythrin) and anti-CD8 (FITC) 
mAb, and they were analyzed  by flow cytometry. 
Examination of peripheral blood T  cells revealed adequate 
numbers ofCD4 + T  cells but a marked paucity ofCD8 + T 
cells  (Fig.  1 A); very few CD3 §  CD8 +  cells  could be de- 
tected  (<1%).  Approximately  40%  of peripheral  blood 
MNC  were  CD19 +  B  cells.  T  cell proliferative  responses 
and  IL-2 production to a variety of stimuli  (phytohemag- 
glutinin,  anti-CD3,  anti-CD2,  anti-TCR)  were  virtually 
absent.  In contrast, the combination ofphorbol ester/iono- 
mycin triggered a normal, IL-2-dependent proliferative re- 
sponse  (Mazer,  B.M.,  A.  Hayward,  and  E.  W.  Gelfand, 
manuscript in preparation). 
At ~6  mo of age,  a  thymus biopsy was performed,  re- 
vealing essentially normal architecture  and the presence  of 
Hassall's corpuscles.  Single-cell preparations  were analyzed 
(Fig.  1  B).  The  majority  of thymic  cells  were  doubly 
stained  for CD4  and  CD8,  ~-'9% were  single  CD4 +,  and 
few if any CD8 + single positive were detected. 
Signaling through the TCR Mediates Changes in [Ca2+]i in 
Thymocytes,  but  not  in  Peripheral  T  Cells in  this Patient. 
The  immunologic  studies  suggested  that  this  patient's 
CD4 + peripheral blood T  cells might have impaired signal 
transduction  function  through  the  TCR.  Changes  in 
[Ca2+]i  after  TCR.  stimulation  with  an  anti-CD3  mAb 
were therefore examined by fluorimetry. After stimulation 
with  anti-CD3  mAb,  a  rapid  and  sustained  increase  in 
[Ca2+]i  was observed in T  cells from a normal individual's 
PBMCs (Fig. 2 A). In contrast, no changes in [Ca2+]i were 
observed in the patient's PBMCs (Fig. 2  B).  Similarly, un- 
like the responses observed in cells  from normal individu- 
als,  stimulation  of this  patient's  PBMCs  with  anti-CD2 
mAbs or phytohemagglutinin also failed to induce increases 
in  [Ca2+]i (data not shown).  However,  addition  of alumi- 
num fluoride to the patient's cells,  which mobilizes [Ca2+]i 
through  mechanisms  involving  guanine  nucleotide-bind- 
ing  proteins,  induced  a  rapid  and  sustained  increase  in 
[Ca2+]i (data not shown). This latter result suggests that the 
phosphatidylinositol  signal  transduction  pathway,  which 
regulates  increases  in  [Ca2+]i induced  by the  TCR.,  albeit 
through a distinct PLC, is intact in the patient's cells.  Col- 
lectively,  these  observations  demonstrate  that  the  TCRs 
t- 
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Figure 2.  The TCP, on the thymocytes  but not on the peripheral blood 
T cells can induce increases in  [Ca2+]i  . Indo-l-loaded PBMCs from a 
normal individual (A), PBMCs from the patient (B), thymocytes from a 
normal individual (C), or thymocytes from the patient (D) were stimu- 
lated with anti-CD3 mAb as indicated, and changes in [Ca2+]i  were mon- 
itored by fluorimetry over time. 
expressed by the CD4 + T  cells in this patient were unable 
to  couple  to  TCR-regulated  mechanisms  responsible  for 
increases in [Ca>]i. 
In view of the  paradoxical  presence  of CD4  cells  with 
impaired TCR  signal transduction function in the periph- 
eral blood of this patient,  the  signal transduction  function 
of TCRs on the thymocytes from this patient was of great 
interest.  In contrast to the PBMCs from this patient,  addi- 
tion of anti-CD3 antibody to thymocytes isolated from the 
biopsy specimen  from this  patient  resulted  in a  rapid  and 
sustained  increase  in  [Ca2+]i  (Fig.  2  D).  This  increase  in 
[Ca2+]i was similar in magnitude to the changes observed in 
thymocytes isolated  from a  normal  individual  (Fig.  2  C). 
Indeed, in additional  experiments using flow cytometry to 
monitor calcium changes in individual  cells,  >80% of the 
patient's  thymocytes  responded  to  the  anti-CD3  mAb. 
Since  the  patient's  thymocyte  population  was  predomi- 
nantly composed ofCD4+/CD8 + (double-positive) imma- 
ture thyrnocytes (86%), these studies suggest that TCRs ex- 
pressed  on  these  immature  double  positive  thymocytes 
were  able  to mediate  early signal  transduction  events  and 
increases in [Ca2+]i  . 
ZAP-70  is  Deficient  in  the  Patient's  PBMCs  and  in  a 
Thymic Line Derived  from the Patient.  To  define  the  mo- 
lecular basis  for the TCFL signal transduction defect result- 
ing in differences in the signaling capacity of this patient's 
PBMCs and thymocytes, we analyzed several PTKs impli- 
cated in TCR  signaling. As shown in Fig. 3 A, normal lev- 
els  of Lck were  detected  in whole-cell lysates  of PBMCs 
from this patient,  but no ZAP-70 protein was detected by 
Western blotting using an mAb directed against the NH2- 
terminal region encompassing the SH2 domains of ZAP-70. 
To define  the  molecular basis for the  failure  of this pa- 
tient's peripheral blood CD4 + cells to express ZAP-70 pro- 
tein, and to understand the differential signaling capacity of 
TCR.s  in  the  thymus  and  PBMCs,  an  HTLV-l-trans- 
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ZAP-70 protein in the patient's 
peripheral blood T  cells and in 
an  HTLV-l-transformed  thy- 
mocyte derived from the patient. 
Whole-cell lysates from PBMCs 
(A)  or  from  HTLV-l-trans- 
formed lines derived from thy- 
mocytes  (B)  isolated from the 
patient (Pt) or from immunolog- 
ically  normal individuals  (C) 
were probed  by  Western blot 
analysis for  the  indicated pro- 
teins.  Equivalent  numbers  of 
cells were used in each of these 
experiments. 
formed  polyclonal  cell  line  was  derived  from  the  thy- 
mocytes of this patient as well as from the thymocytes of an 
immunologically  normal  individual  undergoing  cardiac 
surgery. Like the patient's peripheral  blood CD4 +  T  cells, 
the  patient's  CD4 +  thymocyte line  also  failed  to  express 
ZAP-70 protein as assessed  by Western blot analysis (Fig. 3 
B). This is in marked contrast to the ZAP-70 protein easily 
detected  in  lysates  from the  control  thymocyte line.  The 
patient's HTLV-1 thymocyte line expressed Lck and TCR-~ 
(Fig. 3  B),  as well as CD4,  Fyn, PLC-~/1, and CD3~  (data 
not shown). Despite the somewhat reduced levels of  TCR-~, 
the  TCR  level  on  the  plasma  membrane  of the  patient's 
line  was  comparable  to  that  of the  control line.  Interest- 
ingly, the patient's HTLV-1 line expressed higher levels of 
Syk when compared to the control line.  This was verified 
in  separate  experiments  using independently  derived  anti- 
Syk rabbit heterosera.  We were unable to analyze levels of 
Syk protein in the peripheral blood T  cells from the patient 
since limited  quantities  of peripheral  blood were  available 
and  Syk  is  expressed  at  high  levels  in  monocytes  and  B 
cells,  but only at very low levels in normal T  cells. 
The failure of this patient's PBMCs to mediate increases 
in [Ca2+]i,  together with the deficiency in ZAP-70 protein, 
is  consistent  with  recent  reports  of patients  with  a  similar 
peripheral  blood T  cell phenotype  and signal transduction 
defect  (7,  9).  Previous  studies  (7-9)  demonstrated  muta- 
tions in the coding sequence of the ZAP-70 kinase domain 
in several independent  families.  In an  effort to further de- 
fine  the  molecular  basis  for the  failure  of the  patient's  T 
cells to express ZAP-70 protein,  Northern blots were pre- 
pared with whole-cell RNA  isolated from the patient  and 
control thymocyte lines.  In contrast to previous reports  of 
ZAP-70-deficient patients, no ZAP-70 RNA could be de- 
tected in the thymocyte line derived from the patient  (Fig. 
4). The consanguinity present in this family is likely to have 
contributed  to  this  defect resulting  from the  homozygous 
inheritance  of two alleles  of ZAP-70 that are transcription- 
ally silent.  Further molecular analysis of this patient's ZAP- 
Figure 4.  The patient's thymocyte 
line  fails to  express ZAP-70  tran- 
scripts. Total cellular RNAs derived 
from the patient's (Pt) or the  con- 
trol's  (C)  HTLV-l-transformed 
thymocyte  line were assessed by 
Northern  blot analysis for ZAP-70 
or [3-actin transcripts. 
70 gene is in progress but preliminary Southern blot analy- 
sis has failed to reveal gross deletions  in the  ZAP-70 gene 
(data  not  shown).  Collectively,  these  studies  suggest  that 
the TCR  on CD4 + peripheral T  cells from this patient fail 
to signal because of the absence of ZAP-70 transcripts and 
protein. 
The  TCR  on  the Patient's  Thymocyte Line Is  Competent  to 
Mediate Signal  Transduction  Events.  In  an  effort  to  further 
understand  the  molecular  basis  for  the  differential  signal 
transduction  capability  of the  TCR  on  the  patient's  thy- 
mocytes  and  peripheral  T  cells,  the  signal  transduction 
function  of the  TCR  on  the  HTLV-l-transformed  thy- 
mocyte line was analyzed by examining changes in [Ca2+]i . 
The  control  and patient  lines were  rested  for  16  h  in  the 
absence of exogenous IL-2 before stimulation of the TCR 
with anti-CD3  mAb.  Similar to the response of the TCRs 
on  thymocytes  from  the  patient's  biopsy  (Fig.  2  D),  the 
TCR  on  the  patient's  HTLV-l-transformed  thymocyte 
line  responded  to  anti-CD3  mAbs,  with  increases  in 
[Ca2+]i (Fig. 5  B), although somewhat delayed when com- 
pared to those of the control thymocyte (Fig. 5 A). The pa- 
tient's  thymocyte  line  thus  appears  to  express  a  TCR 
which,  like  the  freshly  isolated  thymocytes from this  pa- 
tient,  is  able to induce  a  signal transduction  event charac- 
teristic of the TCR  on normal T  cells  and thymocytes. 
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Figure 5.  The TCR on the patient's HTLV-l-transformed thymocyte 
line can induce increases in [Ca2+]i . Indo-l-loaded control (A) or patient 
(B) HTLV-l-transformed thymocyte lines were stimulated with biotiny- 
lated anti-CD3 mAb (Leu4-B) followed by streptavidin (A) as indicated. 
Changes in [Ca2+]i  were monitored by fluorimetry. 
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TCR on the Thymic Line.  Because  of the  limited  patient 
material available, signal  transduction function of the TCR 
was  studied  in  more  detail  with  the  available  HTLV-1- 
transformed  thymocyte  line.  Since  previous  reports  of 
ZAP-70-deficient peripheral T  cells demonstrated a failure 
of these cells  to mediate an increase in the tyrosine phos- 
phorylation of several cellular substrates,  including PLC~I 
(7,  9),  we  examined whole-cell lysates  from control and 
patient HTLV-l-transformed thymocyte lines after stimu- 
lation with anti-CD3 mAb.  Similar to the rapid induction 
of tyrosine phosphoproteins observed in  the  control thy- 
mocyte line, increases in tyrosine phosphoproteins could be 
observed after stimulation of the TCR on the patient thy- 
mocyte line (Fig.  6 A). Virtually identical results were ob- 
tained  regardless  of whether  the  TCR  was  cross-linked 
with anti-CD3 mAb alone or after co-cross-linking with a 
combination  of anti-CD4  and  anti-CD3  mAbs  (data  not 
shown). Interestingly, the pattern of tyrosine phosphopro- 
teins in the patient's thymocyte line differed from the con- 
trol thymocyte line.  Notably, prominent  70-  and  72-kD 
tyrosine  phosphoproteins  were  observed  in  the  control 
line,  while  only  a  72-kD  tyrosine  phosphoprotein  was 
abundant in the patient line. In addition, a protein migrat- 
ing at ~24 kD was observed in the control line but not in 
the patient line. This phosphoprotein may represent a TCR-~ 
chain and/or CD3 components (see below). These results 
suggest that the TCR in the patient thymocyte line is able 
to couple to cytoplasmic PTKs. 
Induction oftyrosine phosphoproteins after TCR stimu- 
lation of the patient's  thymocyte line was  somewhat sur- 
prising  since  previous  studies  of the  TCR  in  peripheral 
blood  T  cell  from patients  with  ZAP-70  deficiency had 
Figure  6.  Stimulation of the TCR  on the patient's thymocyte line in- 
duces increases in  cellular  tyrosine  phosphoproteins including Syk.  (A) 
Whole-cell lysates from the control thymocyte line (C)  or from the pa- 
tient's thymocyte line (Pt) were prepared before (-)  or after stimulation 
with biotinylated anti-CD3 mAb and streptavidin (+)  and blotted with 
an antiphosphotyrosine mAb. (B) Syk (lanes 5-8) or ZAP-70 (lanes 9-12) 
immunoprecipitates were  isolated using rabbit  heterosera from the lines 
before or after stimulation and blotted with an antiphosphotyrosine mAb. 
(C) TCR-{ immunoprecipitates (lanes 13-16),  isolated from control and 
patient lines before and after stimulation using an anti-TCR-~ heterose- 
ram, were probed with an antiphosphotyrosine mAb. Note that the band 
running below ZAP-70 in lane  10 likely represents Lck,  since Lck and 
ZAP have been shown to coprecipitate with the { chain. 
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shown a relative failure to induce tyrosine phosphoproteins 
after receptor stimulation (7-9). The ability of the patient's 
thymocytes and  the  HTLV-l-transformed thymic line  to 
signal  in  the  absence of ZAP-70,  was  further assessed by 
immunoprecipitation  of Syk,  ZAP-70,  and  the  ~  chain 
from the control and patient thymic lines before and after 
TCR stimulation.  Stimulation of the TCR in the control 
line resulted in the induction of prominent tyrosine phos- 
phorylation of ZAP-70, as well as the ~ chain (Fig. 6, lanes 
10  and  14),  but  relatively minimal  induction  of Syk ty- 
rosine phosphorylation (Fig.  6, lane 6). ZAP-70 immuno- 
precipitates from the control line contained only low levels 
oftyrosine-phosphorylated ~ chain in the basal state (Fig. 6, 
lane 9) but an increased level from stimulated cells  (Fig. 6, 
lane  10).  In marked contrast, no tyrosine phosphorylation 
of the  ~  chain  was  observed in  Syk immunoprecipitates, 
despite the  modest induction of tyrosine phosphorylation 
of Syk in the control line. Prolonged exposures of this blot 
failed to demonstrate an association between Syk and the 
chain or CD3 chains in the control line. Thus, in the con- 
trol line, there was a marked increase in the tyrosine phos- 
phorylation of ~ and ZAP-70 but only a modest increase in 
Syk phosphorylation.  No  association between  Syk and 
was observed after TCR stimulation. 
In contrast to the response in the control line, Syk was 
more highly phosphorylated after TCR stimulation of the 
patient thymocyte line (Fig.  6, lane 8). These findings sug- 
gest that Syk undergoes very prominent phosphorylation in 
the  absence  of ZAP-70.  In  part,  this  could  reflect  the 
higher levels of Syk expression in the patient line  (Fig.  3 
B). Despite this marked degree of tyrosine phosphorylation 
of Syk,  no  associated  ~ chain was  coimmunoprecipitated 
with Syk, nor was the ~ chain detectably tyrosine phosphor- 
ylated in the patient line (Fig. 6, lanes 8 and I6). Thus, Syk 
does not appear to form a stable complex with ~, nor could 
we  detect  the  induced  tyrosine phosphorylation of ~.  In 
other experiments, we were also  unable to detect tyrosine 
phosphorylation of the CD3 chains (including CD3{) in the 
patient  line  after  TCR  stimulation  (data  not  shown). 
Moreover, we were unable to detect the FcR~/chain in ly- 
sates of the thymic cell line by immunoblotting (in contrast 
to a rat basophilic leukemia cell line as a control, data not 
shown), eliminating the possibility of Syk association with 
the TCR via phosphorylated FcR% These findings suggest 
that Syk can couple to the TCR signaling pathway in the 
absence of ZAP-70, though its interaction with the TCR 
may differ qualitatively or quantitatively. 
Discussion 
At least  four cytoplasmic PTKs have been shown to in- 
teract with the TCR and to contribute to its signal  trans- 
duction function: Fyn, Lck, ZAP-70, and Syk. The conse- 
quences of mutations in three of these PTKs have resulted 
in  rather  distinct  phenotypes  in  mice  whose  genes  have 
been purposefully disrupted,  or in  humans  whose  disease 
results  from inherited mutations. The resultant phenotypic abnormalities provide unique insights into the role of TCR 
signal  transduction  and these  PTKs in  TCR  function and 
in T  cell development. 
In mice lackingfyn  as a result of gene disruption, general 
features of T  cell subset maturation are not altered and the 
numbers ofT cells in the thymus, and peripheral lymphoid 
organs are preserved (16,  17). The loss of Fyn has the great- 
est impact in TC1L signal transduction function within the 
most  mature  single  positive  (CD4  +  or  CD8 +)  subsets  of 
thymocytes,  whereas  the  signal  transduction  function  of 
TCRs on peripheral T  cells appears to be restored to a large 
extent  (16,  17). There is an impairment in signal transduc- 
tion through  the  GPI-linked molecule  Thy-1  (17).  These 
observations suggest that the function of Fyn in TCR  sig- 
naling  may  be  most  important  in  a  developmentally  re- 
stricted compartment or in signal transduction via receptors 
other than the TCR. 
In contrast to fyn,  disruption  of the  lck gene  results  in a 
severe arrest of thymocyte development at a very immature 
stage,  the  transition  from double  negative  (CD4-/CD8-) 
to  double  positive  (CD4+/CD8 +)  thymocytes  (20).  A 
small  number of T  cells  are  found in  the  peripheral  lym- 
phoid  tissues.  Whether  this  occurs  via  compensatory up- 
regulation of other PTKs was not examined.  The few pe- 
ripheral  T  cells  that  do  develop  and  populate  peripheral 
lymphoid organs also exhibit diminished responses to typi- 
cal TCR  stimuli,  suggesting an impairment in TCR  signal 
transduction  function.  This  is  consistent  with  the  loss  of 
TC1L  signal  transduction  function  in  a Jurkat-derived  T 
cell  mutant  line  and  in  a  cytolytic T  cell  clone  that were 
found to be deficient in Lck kinase expression (18,  19). Lck 
also appears to play a role in allelic exclusion of  the TC1L-[3 
chain  (35).  These  observations  suggest  that  Lck  plays  a 
prominent role in TC1L signal transduction and contributes 
to developmental decisions early during thymic ontogeny. 
In humans,  mutations  in  the  ZAP-70  gene  that  impair 
expression  or  function  give  rise  to  a  phenotype  that  is 
clearly distinct from the deletions offyn or lck. The periph- 
eral blood and thymus are deficient in CD8 +  T  cells,  and 
circulating CD4 + T  cells fail to signal appropriately through 
the TCR. There is a failure of protein tyrosine phosphory- 
lation  and the  mobilization  of [Ca2+]i after TC1L stimula- 
tion,  suggesting that  ZAP-70  is  essential  for TCR-medi- 
ated  signaling  in  CD4 +  cells.  Moreover,  it  would  appear 
that  redundant  pathways  or  compensatory changes  in  the 
functions  of other  PTKs  are  not  present  or  certainly  not 
detectable  in  the  ZAP-70-deficient  peripheral  CD4 +  T 
cells.  Since there are abundant  numbers of double positive 
(cortical) and CD4 + (medullary) thymocytes with a paucity 
of CD8 +  (medullary)  thymocytes,  this  also  implies  that 
ZAP-70 may not be essential  for the  transition  of double- 
positive CD4+/CD8 + thymocytes to single positive CD4 + 
Figure 7.  Scheme for T cell selection in the absence ofZAP-70. ZAP-70 may be indispensable for maturation into CD8 + T cells but not CD4 + T cells. 
For CD4 + T cell selection in the thymus, Syk may be capable of compensating for the loss of ZAP-70. In addition, the differential level of association uf 
Lck with CD4 and CD8 is shown. 
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patients,  it appears that ZAP-70 may be indispensable for 
maturation into CD8 + T  cells,  but not CD4 + T  cells  (see 
model in Fig. 7). 
The homologous 72-kD  PTK Syk may also  play a role 
in TCP,. signal transduction.  As observed for the  stimula- 
tion  of ZAP-70,  TCP, stimulation  results  in  the  tyrosine 
phosphorylation of Syk and the association of phosphory- 
lated  ~ with  Syk in  the Jurkat T  lymphoblastoid cell line 
and  in  a  heterologous  Cos  cell  expression  system  (22). 
Moreover,  chimeras in  which  Syk has been  fused to  an- 
other transmembrane receptor can initiate signal transduc- 
tion events similar to those induced by the stimulated TCP, 
(36). Thus, Syk may play a role in TCP, signal transduction 
that is similar, though perhaps not identical to that of ZAP- 
70.  In the  thymus,  where  expression of Syk is highest in 
the T  cell lineage (22),  Syk may be capable of compensat- 
ing for the loss of ZAP-70. This may account for the ability 
of the TCR on thymocytes in ZAP-70-deficient individu- 
als  to  mediate  signal  transduction  events.  This  could,  in 
turn,  permit  the  CD4 +  lineage  cells  to  be  positively se- 
lected and circulate in the peripheral blood (Fig.  7). 
The evidence that Syk is coupled to the TCP, and can 
compensate for the loss of ZAP-70 in the thymus of these 
patients  is  supported  by our observations of the  patient's 
HTLV-l-transformed thymocyte line which, like the fresh 
thymocytes from this patient,  signaled through  the TCR.. 
This suggests that the TCP, in this line is coupled to cyto- 
plasmic PTKs. After TCR stimulation, Syk was rapidly ty- 
rosine phosphorylated in  this  ZAP-70-deficient  cell.  This 
also occurred in the control thymocyte cell line, but not to 
the same extent. The smaller degree oftyrosine phosphory- 
lation of Syk in the control line could reflect its competi- 
tion with ZAP-70 for interaction with the TCP,. Alterna- 
tively, it could reflect the lower levels of Syk expression in 
the ZAP-70-positive control line.  The higher level of ex- 
pression of Syk in the ZAP-70-deficient cells might repre- 
sent  a  compensatory  mechanism  in  response  to  ZAP-70 
loss. Unfortunately, this could not be confirmed with fresh 
ZAP-70-deficient thymocytes from this patient since they 
were not available for analysis.  The HTLV-l-transformed 
thymocyte  cell  line  from  the  patient  resembled  his  thy- 
mocytes in that the levels of Syk were higher than in pe- 
ripheral T  cells. The downregulation of Syk expression that 
occurs in peripheral T  cells, as has been described in normal 
humans and mice, could account for the loss of TCR signal 
transduction function in the peripheral blood CD4 + T  cells 
in ZAP-70--deficient patients. 
If Syk compensates for the loss of ZAP-70  in  the  thy- 
mus, the failure of Syk to participate in the positive selec- 
tion  of CD8 +  cells  must be  explained.  One  possibihty is 
that differentiation towards the CD4 rather than the CD8 
lineage reflects the involvement of a  more efficient signal 
transduction  mechanism.  If Syk is  unable  to fully replace 
the function  of ZAP-70,  signal transduction  by the TCR. 
in the thymus might be partially compromised. Since Lck 
has a  greater association with  CD4  than  CD8  in  double- 
positive thymocytes, this  may contribute  to  a preferential 
selection of the CD4 lineage (37). Thus, signal transduction 
by the  TCR  in  ZAP-70-deficient  thymocytes may only 
reach  an  appropriate  threshold  in  the  events  leading  to 
CD4 but not CD8 lineage selection. 
An unexpected finding in these studies was the failure to 
detect  tyrosine-phosphorylated  Syk  associated  with  ~  or 
CD3 after TCP, stimulation in either of the HTLV-I thy- 
mocyte lines. We also failed to detect any phosphorylated 
or  CD3  chains  in  the  ZAP-70--deficient line  after TCP, 
stimulation despite the inducible  tyrosine phosphorylation 
of Syk and other proteins. It is possible that the interaction 
of Syk with the TCR is a transient event in these HTLV-1 
lines.  Alternatively,  these  lines  might  express  regulatory 
proteins that cause a rapid dissociation of the SH2 domains 
of Syk from the phosphorylated tyrosine residues contained 
in the activation motifs present in  the ~ and CD3  chains. 
Another possibility is raised by the studies of Couture et ai. 
(31),  who suggested that Syk might function  upstream of 
Lck and ZAP-70. Syk levels, however, are very tow in pe- 
ripheral T  cells where signaling does not appear to occur in 
the absence of ZAP-70, and we have not been able to re- 
produce their findings (data not shown). 
Our studies  provide insights into  mechanisms that may 
explain the paradoxical phenotype of peripheral T  cells in 
ZAP-70-deficient patients. The ability of the TC1L to dif- 
ferentially signal in the thymus but not in peripheral CD4 + 
ceils offers an explanation for how CD4 + cells are selected. 
Our results suggest that in the absence ofZAP-70, Syk may 
play a  compensatory role in  regulating this positive selec- 
tion (Fig.  7).  The preferential selection of CD4 + cells may 
reflect  an  increased  association  of Lck  with  CD4  rather 
than CD8.  Thus, in a cell with a compromised TCP, sig- 
naling pathway because of ZAP-70 deficiency, only the se- 
lection events that involve CD4 coreceptors may yield fig- 
nals  of sufficient magnitude for further differentiation into 
more mature cells. The absence of single positive CD8 cells 
in  the  thymus  of these  patients  supports  the  notion  that 
positive selection occurs at the transition of double-positive 
to single-positive cells.  Downregulation of Syk during de- 
velopment  and/or  the  absolute  requirement  for  ZAP-70 
may explain why peripheral CD4 + T  cells lacking ZAP-70 
do not have signal competent TCRs. 
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